United States · FDA National Drug Code directory

Oxaprozin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 55111-170_4aa1c6b5-21ff-e110-63cf-a5c0f1b66493
Product NDC: 55111-170
Form: TABLET, FILM COATED
Composition / generic term: Oxaprozin
Labeler: Dr. Reddy's Laboratories Limited
Marketing category: ANDA
Marketing start / end (source format): 20010131
Source listing expiry: 20271231

Source-listed ingredients

OXAPROZIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, FILM COATED in 1 BOTTLE (55111-170-01) · 55111-170-01
500 TABLET, FILM COATED in 1 BOTTLE (55111-170-05) · 55111-170-05

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →